See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

Vignettes on Plaque Stability 1: Insights from the VH Registry and HORIZONS-AMI

Presenter: Akiko Maehara

October 23, 2012

Presentation TCT 2012

Overview: Addressing Structure in Structural Heart Disease

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

TCT-57. Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial

Presenter: Sorin Brener

October 23, 2012

Presentation TCT 2012

TCT-78. Long-Term (4-Year) Clinical Outcomes of Total Occlusions and Completeness of Revascularisation in the Synergy between Percutaneous Coronary Intervention with Taxus and...

Presenter: Vasim Farooq

October 23, 2012

Presentation TCT 2012

Introduction(12)

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Concurrent Coronary Artery and Valvular Heart Disease 2: Hybrid PCI with Transcatheter Valves

Presenter: Jean-Michel Paradis

October 23, 2012

Presentation TCT 2012

PCSK9 Inhibitors: The Holy Grail?

Presenter: Evan Stein

October 23, 2012

Presentation TCT 2012

Inspiron (Scitech) Program Update

Presenter: Pedro Lemos

October 23, 2012

Advertisement

Slides

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Hypertension: Renal Denervation

Vignettes on Plaque Stability 1: Insights from the VH Registry and HORIZONS-AMI

Overview: Addressing Structure in Structural Heart Disease

TCT-57. Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial

TCT-78. Long-Term (4-Year) Clinical Outcomes of Total Occlusions and Completeness of Revascularisation in the Synergy between Percutaneous Coronary Intervention with Taxus and...

Introduction(12)

Concurrent Coronary Artery and Valvular Heart Disease 2: Hybrid PCI with Transcatheter Valves

PCSK9 Inhibitors: The Holy Grail?

Inspiron (Scitech) Program Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content